DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 1Dr. Reddy's Laboratories
02 1Biophore India Pharmaceuticals Pvt Ltd
03 1Chunghwa Chemical Synthesis & Biotech
04 1TAPI Technology & API Services
05 1Allite (Shanghai) Pharmaceutical Technology
06 1Chongqing Carelife Pharmaceutical
07 1Chongqing Pharmaceutical Research Institute Co Ltd
08 1Chongqing Sintaho Pharmaceutical
09 1Fresenius Kabi Oncology Limited
10 1Hansoh Pharma
11 1Hetero Drugs
12 1Intas Pharmaceuticals
13 1Laurus Labs
14 1Lunan Pharmaceutical
15 1MSN Laboratories
16 1Polymed Therapeutics Inc.
17 1Qilu Pharmaceutical
18 1SEACROSS PHARMACEUTICALS
19 1Sichuan Huiyu Pharmaceutical
20 1Blank
Reset all filters
01 14CARFILZOMIB
02 1CARFILZOMIB (NON-STERILE BULK DRUG SUBSTANCE)
03 1CARFILZOMIB (NON-STERILE, API)
04 1CARFILZOMIB DRUG SUBSTANCE
05 1CARFILZOMIB NON-STERILE BULK DRUG SUBSTANCE
06 1CARFILZOMIB [ROUTE CODE "CJ"]
07 1CARFILZOMIB, NON-STERILE, BULK DRUG SUBSTANCE
Reset all filters
01 8China
02 7India
03 1Israel
04 1Taiwan
05 1U.S.A
06 1United Kingdom
07 1Blank
Reset all filters
01 16Active
02 4Inactive
Reset all filters
01 11Complete
02 9Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2016-07-06
Pay. Date : 2016-05-04
DMF Number : 30402
Submission : 2016-03-29
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Complete
Rev. Date : 2024-09-19
Pay. Date : 2024-08-27
DMF Number : 32406
Submission : 2017-12-30
Status : Active
Type : II
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31276
Submission : 2016-12-30
Status : Inactive
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2016-02-25
Pay. Date : 2015-12-21
DMF Number : 30124
Submission : 2016-01-21
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-07-03
Pay. Date : 2023-05-18
DMF Number : 38180
Submission : 2023-05-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-10-09
Pay. Date : 2020-09-01
DMF Number : 35083
Submission : 2020-09-08
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-04-19
Pay. Date : 2016-01-20
DMF Number : 30115
Submission : 2016-03-22
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-11-16
Pay. Date : 2015-09-23
DMF Number : 29671
Submission : 2015-08-29
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30357
Submission : 2016-02-26
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2016-02-05
Pay. Date : 2015-09-25
DMF Number : 29770
Submission : 2015-09-28
Status : Active
Type : II
33
PharmaCompass offers a list of Carfilzomib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Carfilzomib manufacturer or Carfilzomib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carfilzomib manufacturer or Carfilzomib supplier.
PharmaCompass also assists you with knowing the Carfilzomib API Price utilized in the formulation of products. Carfilzomib API Price is not always fixed or binding as the Carfilzomib Price is obtained through a variety of data sources. The Carfilzomib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Carfilzomib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carfilzomib, including repackagers and relabelers. The FDA regulates Carfilzomib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carfilzomib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carfilzomib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Carfilzomib supplier is an individual or a company that provides Carfilzomib active pharmaceutical ingredient (API) or Carfilzomib finished formulations upon request. The Carfilzomib suppliers may include Carfilzomib API manufacturers, exporters, distributors and traders.
click here to find a list of Carfilzomib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Carfilzomib DMF (Drug Master File) is a document detailing the whole manufacturing process of Carfilzomib active pharmaceutical ingredient (API) in detail. Different forms of Carfilzomib DMFs exist exist since differing nations have different regulations, such as Carfilzomib USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Carfilzomib DMF submitted to regulatory agencies in the US is known as a USDMF. Carfilzomib USDMF includes data on Carfilzomib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carfilzomib USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Carfilzomib suppliers with USDMF on PharmaCompass.
We have 19 companies offering Carfilzomib
Get in contact with the supplier of your choice: